長榮股份(300195.SZ):子公司取得醫療器械註冊證和醫療器械生產許可證
格隆匯3月18日丨長榮股份(300195.SZ)公佈,公司於2020年2月26日投資設立子公司長榮健康,研發、生產、銷售醫用口罩生產設備,生產銷售醫用口罩,拓展醫療健康領域業務,力求緩解疫情防控形勢下市場對醫用口罩的急需。
公司於2020年3月17日收到長榮健康通知,長榮健康已取得由天津市藥品監督管理局核准頒發的《醫療器械註冊證》和《醫療器械生產許可證》。其中醫療器械註冊證註明產品名稱為一次性使用醫用口罩,而醫療器械生產許可證註明生產範圍為Ⅱ類;14-14一次性使用醫用口罩。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.